India's Pharma Industry at a Glance: Size, Growth, and Global Position
For any international buyer sourcing pharmaceutical products, understanding India's position in the global industry is useful context — it explains why India is a natural sourcing destination and what the country's manufacturing strengths and limitations actually are.
---
India's Global Position
India is consistently ranked among the world's largest pharmaceutical producers and exporters. Key dimensions of that position:
Volume of generic medicines: India is one of the world's largest exporters of generic pharmaceutical formulations, supplying a substantial share of the generics consumed in markets including the United States, United Kingdom, and across Africa and Southeast Asia. The country's pharmaceutical export reach is genuinely global. Manufacturing breadth: Indian manufacturers produce a wide range of products — from basic antibiotics and paracetamol to complex formulations in oncology, cardiovascular, and anti-infective categories. API (Active Pharmaceutical Ingredient) manufacturing is also a significant Indian industry segment, supplying raw materials to manufacturers worldwide. Regulatory approvals: India has among the highest numbers of US FDA-approved manufacturing facilities outside the United States. A large number of Indian facilities also hold EU-GMP certification, WHO-GMP, and other international quality credentials — enabling supply to regulated markets that require these standards. (For specific figures on export value, facility counts, and market rankings, refer to Pharmexcil's annual export reports, IBEF's pharmaceutical sector overview, and CDSCO's published data — these are updated periodically and are the authoritative sources.)---
The Manufacturing Base
India's pharmaceutical manufacturing is distributed across multiple states, with key clusters in:
- Telangana and Andhra Pradesh: Hyderabad's "Genome Valley" is a major pharmaceutical and biotech hub, with large-scale API and formulation manufacturing - Gujarat: Ahmedabad and Vadodara have significant pharmaceutical manufacturing clusters, particularly in APIs and formulations - Maharashtra: Mumbai's extended industrial zones (Thane, Navi Mumbai, Pune) host numerous formulation manufacturers - Himachal Pradesh and Uttarakhand: Tax-incentive zones attracted significant formulation manufacturing capacity - Karnataka: Bangalore hosts biotech and specialty pharma companies
---
API Manufacturing: India's Upstream Strength
India's API (Active Pharmaceutical Ingredient) sector is a significant upstream strength. Indian API manufacturers supply:
- Bulk APIs to Indian and global formulation manufacturers - Export directly to pharma manufacturers in regulated and developing markets
The Indian government's PLI (Production-Linked Incentive) scheme for key starting materials (KSMs), drug intermediates, and APIs — launched with the objective of reducing import dependence on Chinese API sources — is building additional domestic API capacity in targeted categories.
For buyers of finished formulations, India's strong API base means greater supply chain depth and, in many cases, vertically integrated manufacturers who control their raw material supply.
---
Regulatory Environment
India's pharma regulatory framework is administered by CDSCO at the central level and State Drug Controllers at the state level. Key regulatory milestones:
- New Drugs and Clinical Trials Rules, 2019 (NDCT Rules): Modernised the clinical trial and new drug approval framework - Revised Schedule M (2023): Upgraded domestic GMP standards to better align with international expectations - Medical Devices Rules, 2017: Brought medical devices under formal regulatory oversight - Pharmacovigilance Programme of India (PvPI): Post-market surveillance system
These regulatory developments have progressively strengthened the quality oversight framework — relevant for buyers who want to understand the environment in which Indian manufacturers operate.
---
What This Means for Buyers
India's pharmaceutical industry offers buyers:
- Breadth: Wide product range across therapeutic categories and dosage forms - Price competitiveness: Particularly for generic formulations - Quality depth: Significant number of internationally certified manufacturers - Established export infrastructure: Experienced exporters, freight forwarders, and logistics providers with pharma-specific capability
The appropriate due diligence is to select suppliers — manufacturers and traders — who have the specific certifications, documentation capability, and product range that match your market's requirements.
---
Bharat Medex is a Nagpur-based pharmaceutical trader with 19 years of experience in ethical medicines, generics, and surgical items for domestic and international buyers.
Contact us to discuss your sourcing requirements.
0 comments